SCHEMBL426126

SCHEMBL426126

CCCC(O)CCC(C)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.42
FDPS P14324 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
FFAR4 Q5NUL3 1/20 0.32
FFAR1 O14842 1/20 0.32
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
NFKB1 P19838 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126698 1.00 TSHR (0.42) TSHRFDPSTDP1HSD17B10ALDH1A1
SCHEMBL16348957 0.90 FFAR4 (0.45) FFAR4FFAR1NFKB1SPHK1GPR84
SCHEMBL8061461 0.89 TSHR (0.38) TSHRTDP1HSD17B10ALDH1A1LMNA
SCHEMBL28671408 0.87 TSHR (0.44) TSHRTDP1ALDH1A1LMNAMAPK1
SCHEMBL28568549 0.87 FDPS (0.43) TSHRFDPSTDP1LMNAFFAR4
SCHEMBL30575792 0.87 FDPS (0.43) TSHRFDPSTDP1LMNAFFAR4
SCHEMBL29232764 0.87 FDPS (0.43) TSHRFDPSTDP1LMNAFFAR4
SCHEMBL15855762 0.87 FDPS (0.43) TSHRFDPSTDP1LMNAFFAR4
SCHEMBL3623070 0.87 TSHR (0.44) TSHRTDP1ALDH1A1LMNAMAPK1
SCHEMBL1328891 0.87 FDPS (0.43) TSHRFDPSTDP1LMNAFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2025-02-06 US claimed
EP-4451875-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP Investments LLC (US) 2024-10-30 EP claimed
WO-2023122003-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2023-06-29 WO claimed
US-20230147032-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS HERAEUS EPURIO GMBH (DE) 2023-05-11 US claimed
CN-112724385-B Hydrolysis-resistant flame-retardant polyester and preparation method thereof 中国石油化工股份有限公司 2022-08-12 CN claimed
WO-2021198214-A2 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS Heraeus Deutschland GmbH & Co. KG (DE) 2021-10-07 WO claimed
EP-3889980-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS Heraeus Deutschland GmbH & Co KG (DE) 2021-10-06 EP claimed
CN-112724385-A Hydrolysis-resistant flame-retardant polyester and preparation method thereof 中国石油化工股份有限公司 2021-04-30 CN claimed
US-20160040029-A1 PHOTO-RESPONSIVE HYDROPHILIC COATING EMPIRE TECHNOLOGY DEVELOPMENT LLC 2016-02-11 US claimed
EP-2981591-A2 PHOTO-RESPONSIVE HYDROPHILIC COATING Empire Technology Development LLC (US) 2016-02-10 EP claimed
EP-0888424-A1 FABRIC SOFTENING COMPOUND/COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1999-01-07 EP claimed
CN-1196081-A Concentrated, water dispersible, stable, fabric softening compositions PROCTER & GAMBLE (US) 1998-10-14 CN claimed
CN-1195369-A Concentrated and stable fabric softening compositions PROCTER & GAMBLE (US) 1998-10-07 CN claimed
EP-0842250-A1 CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1998-05-20 EP claimed
EP-0839179-A1 CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-06 EP claimed
US-5747443-A BIODEGRADABLE QUATERNARY AMMONIUM COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1998-05-05 US claimed
WO-1998017756-A1 CONCENTRATED FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1998-04-30 WO claimed
WO-1997034972-A1 FABRIC SOFTENING COMPOUND/COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-09-25 WO claimed
WO-1997003170-A1 CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO claimed
WO-1997003169-A1 CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF RASGRP3, RSU1, RPP30 TSHR 4641/4885FDPS 1515/4885TDP1 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.